To review the role of caspases in programmed cell death (PCD) mechanisms related to sepsis and explore potential therapeutic strategies targeting these pathways.
Approach:
Review of Caspases: The manuscript reviews the classification, structural features, and molecular mechanisms of caspases in regulating PCD pathways during sepsis.
Pathophysiological Role: It clarifies the dual roles of PCD forms in sepsis-induced immune dysregulation and organ damage.
Therapeutic Strategies: The article summarizes therapeutic strategies targeting caspases to develop novel treatments for sepsis.
Key Findings:
Sepsis is characterized by organ impairment due to an uncontrolled systemic reaction to pathogenic infection.
Caspases are central to regulating multiple programmed cell death modalities, including apoptosis, necroptosis, pyroptosis, and PANoptosis.
Dysregulated programmed cell death processes can lead to excessive inflammatory responses, contributing to severe complications in sepsis.
Interpretation:
Understanding the regulatory mechanisms of caspases in PCD is crucial for developing targeted therapies for sepsis.
Limitations:
The review does not provide specific clinical trial data or outcomes related to caspase-targeted therapies.
Potential adverse effects of targeting caspases in clinical settings are not discussed.
Conclusion:
The manuscript emphasizes the central role of caspases in the pathophysiology of sepsis and highlights the need for further research into targeted therapies.
